A carregar...

Myelodysplastic syndromes current treatment algorithm 2018

Myelodysplastic syndromes (MDS) include a group of clonal myeloid neoplasms characterized by cytopenias due to ineffective hematopoiesis, abnormal blood and marrow cell morphology, and a risk of clonal evolution and progression to acute myeloid leukemia (AML). Because outcomes for patients with MDS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Cancer J
Autor principal: Steensma, David P.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5967332/
https://ncbi.nlm.nih.gov/pubmed/29795386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0085-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!